The global self-administered drugs market is anticipated to grow at a CAGR of 8.3% during the forecast period. High healthcare service costs which encourage patients to adopt self-administered drugs also contribute to the growth of this market. Self-administered drugs are majorly taken by diabetic patients for injecting insulin without the prior need of any healthcare professional assistance. The foremost factors leading to the self-administered drug market expansion include the increasing prevalence of diabetes and the rising burden of chronic diseases globally. As per the British Diabetic Association, in the UK, 3.8 million people are living with a diagnosis of diabetes, and 90% of those with type 2, and around 5.5 million people are expected to have diabetes in the UK by 2030.
Get Free Sample link @ https://www.omrglobal.com/request-sample/self-administered-drugs-market
Apart from these, the rising FDA approvals of new drugs developed by prominent players targeting the self-administered drugs market create new growth opportunities for the market. In May 20201, the USFDA approved Eli Lilly and Company’s Mounjaro (tirzepatide) injection. It is a new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. However, lack of awareness about self-administered drugs in emerging countries and low or no reimbursement for some self-administered drugs are the restraints that may hamper the revenue growth of the self-administered drugs market during the forecast period.
A full report of Global Self-Administered Drugs Market available @ https://www.omrglobal.com/industry-reports/self-administered-drugs-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Self-Administered Drugs Market by Product Type
- Injectable Drugs
- Inhaled Drugs
- Transdermal Drugs
Global Self-Administered Drugs Market by Application
- Cardiovascular
- Diabetes
- Osteoporosis
- Pain Management
- Hormone Replacement
- Others
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Abbott Laboratories
- Amgen, Inc.
- Antares Pharma, Inc.
- Baxter International, Inc.
- Bristol-Myers Squibb, Co.
- Eli Lilly & Co.
- Gilead Sciences, Inc.
- Johnson & Johnson Services, Inc.
- Merck & Co. Inc.
- Moderna, Inc.
- Mylan N.V.
- Novartis International AG
- Novo Nordisk AS
- Pfizer, Inc.
- Purdue Pharma LP
- Sanofi S.A.
- Teva Pharmaceuticals Industries, Ltd.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global self-administered drugs market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/self-administered-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
